Department of Pathology, University of Colombo, Colombo, Sri Lanka
Case Report
Ascorbic Acid - A Useful Adjuvant in Refractory Immune Thrombocytopenic Purpura: A Case Report
Author(s): Eindrini C Muhandiram*, Wasanthi Wickramasinghe, Inoshi Atukorala and Lallindra V Gooneratne
Immune Thrombocytopenic Purpura (ITP) is a heterogeneous disease with unpredictable treatment responses. This
unpredictability is attributed in part to different pathogenic mechanisms including oxidative stress. The anti-oxidant effect of ascorbic
acid in treatment of ITP has been described but evidence on its efficacy is contentious.
We describe a patient with refractory ITP in whom ascorbic acid was used as a useful adjuvant treatment. A 60-year old man with diabetes and
hypertension presented with myocardial infarction and underwent primary coronary intervention. He had steroid dependent ITP, with a poor
response to azathioprine, rituximab and splenectomy. He had drug induced cholestasis with dapsone. Therefore high doses of steroids were required to maintain safe platelet counts for antiplatelet drugs, which lead to poor glycemic control. High dose ascorbic.. Read More»
DOI:
10.37421/2165-7920.2022.12.1519
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report